Bristol-Myers Squibb said it will acquire cancer drugmaker Mirati Therapeutics for up to $5.8 billion, diversifying its oncology business and adding drugs it hopes can help offset expected lost revenue from patent...
Sanofi to explore acquisition of cancer drugmaker Mirati, Bloomberg reports
Paris-based drugmaker Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics, Bloomberg News reported on Thursday citing people familiar with the matter. Deliberations are ongoing and there...
US-based Advent seeking investors for Suven-Cohance merger
US-based Advent could rope in new investors into its planned combination of Suven Pharma and Cohance Life Sciences, as it looks to create a top three contract development and manufacturing organisation with a...
IQuest Enterprises acquires Viatris’ Indian API operations
IQuest Enterprises, a multi-sector investment company, said it has entered into a definitive agreement to acquire the API (active pharmaceutical ingredient) operations of global pharmaceutical major Viatris in India...
PE Advent completes acquisition of Suven Pharma, appoints new Board and management team
Private equity firm Advent International announced the completion of its majority acquisition of Hyderabad-based listed contract development and manufacturing organisation (CDMO) Suven Pharma. Advent acquired 50.1%...
Italy’s Alfasigma to buy US liver disease drugmaker Intercept for nearly $800 mln
Italy’s Alfasigma S.p.A agreed on Tuesday to buy drugmaker Intercept Pharmaceuticals for $794 million as it aims to expand its treatment portfolio in liver diseases and digestive system disorders, and bolster...
Novo Holdings, Gurnet Point close $462 million acquisition of Paratek Pharmaceuticals
Novo Holdings, controlling shareholder in drugmaker Novo Nordisk, and Gurnet Point Capital on Thursday closed their acquisition of biopharmaceutical company Paratek Pharmaceuticals in a deal worth $462 million, Novo...
Nirma to buy Glenmark Life Sciences for ₹5,651 crore
Nirma Ltd has agreed to buy 75% of Glenmark Life Sciences Ltd for ₹5,651.5 crore in a deal that values the latter at ₹7,535.4 crore. Mint reported first on 15 August that the cement-to-detergent maker was the sole...
Novo Holdings closes $462 million acquisition of Paratek Pharmaceuticals
Novo Holdings, the controlling shareholder in drugmaker Novo Nordisk, said it had closed its acquisition of biopharmaceutical company Paratek Pharmaceuticals in a deal valued at $462 million. The acquisition of Paratek...
Philip Morris to consider stake sale in biggest pharma unit – WSJ
Marlboro maker Philip Morris International is considering selling a stake in Vectura, its biggest pharmaceutical unit, the Wall Street Journal reported on Tuesday. The tobacco company told the Journal that it was...
Cabinet clears Advent’s acquisition of Suven Pharma for Rs 9,589 crore
The Cabinet Committee on Economic Affairs headed by Prime Minister Narendra Modi on Wednesday approved the FDI proposal for foreign investment of up to Rs.9589 crore in Suven Pharmaceuticals Limited by private equity...
lndiaRF to acquire API, CRAMS business of Ind-Swift Labs
IndiaRF, the India-focused investment platform promoted by Piramal Enterprises and Bain Capital, will acquire the active pharmaceutical ingredients (API) and contract research and manufacturing services (CRAMS) business...
